✦ LIBER ✦

Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients

✍ Scribed by Joshua C. Bis; Nicholas L. Smith; Bruce M. Psaty; Susan R. Heckbert; Karen L. Edwards; Rozenn N. Lemaitre; Thomas Lumley; Frits R. Rosendaal

Book ID: 116207549
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 90 KB
Volume: 16
Category: Article
ISSN: 0895-7061
DOI: 10.1016/j.amjhyper.2003.07.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiotensinogen M235T polymorphism and t

Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or β-blockers

✍ Schelleman, Hedi; Klungel, Olaf H; Witteman, Jacqueline C M; Breteler, Monique M 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Deletion Polymorphism of the Angiotensin

Deletion Polymorphism of the Angiotensin I-Converting Enzyme Gene Associates with Increased Risk for Late Potentials in Patients with Myocardial Infarction

✍ Kenji Nakai; Naoki Chiba; Minoru Shobuzawa; Takehiko Musha; Takahiro Shiroto; Sh 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 601 KB

Risks and benefits of early treatment of

Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: Analysis of the GISSI-3 database

✍ Fausto Avanzini; Gabriele Ferrario; Luigi Santoro; Paolo Peci; Paolo Giani; Euge 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 131 KB

The effect of high plasma levels of angi

The effect of high plasma levels of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor (PAI-1) on the reperfusion after thrombolytic therapy in patients presented with acute myocardial infarction

✍ Ayman A. El Menyar; O. M. Altamimi; Mohamed M. Gomaa; Zainab Fawzy; M. O. Abdel 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 216 KB